252400 Turning Point: Trade Policy and Public Health

Monday, October 31, 2011: 2:30 PM

Ellen R. Shaffer, PhD MPH , Center for Policy Analysis, San Francisco, CA
     
As trade negotiations stall on the global level, publc health advocates are winning greater participation in trade policy, and favorable treatment of some public health protections. At the same time, the brand name pharmaceutical industry and tobacco companies continue to pursue their interests through regional trade agreements. The presentation reviews the status of public health objectives for economically and socially sustainable trade policies, as reflected in the WTO Doha Round, the Trans Pacific Partnership, and other developments.

Learning Areas:
Public health or related public policy

Learning Objectives:
Explain the current state of public health advocacy in trade policy.

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: I regularly write and lecture on trade and health issues.
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.

See more of: Advocacy and Action for Trade and Health
See more of: Trade and Health Forum